AI assistant
Sending…
BALCHEM CORP — Director's Dealing 2025
Apr 12, 2025
31041_dirs_2025-04-11_8378c7d5-e951-4db0-a59c-a64744a4fb63.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: BALCHEM CORP (BCPC)
CIK: 0000009326
Period of Report: 2025-02-12
Reporting Person: Boned Frederic (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-02-12 | Common Stock | A | 1580 | — | Acquired | 6730 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-02-12 | Stock Option | $159.18 | A | 5200 | Acquired | 2035-02-12 | Common Stock (5200) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 312 | Indirect |
Footnotes
F1: Ownership of restricted stock vests in Reporting Person ratably over a 3 year period (25% on the first anniversary of the grant date, 25% on the second anniversary of the grant date, and 50% on the third anniversary of the grant date), subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person.
F2: Options vest 20% Year 1; 40% Year 2: and 40% Year 3.
More from BALCHEM CORP
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Major Shareholding Notification
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 27
Proxy Solicitation & Information Statement
2026
Apr 27
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Feb 20
Regulatory Filings
2026
Feb 20
Regulatory Filings
2026
Feb 19